Skip to Main Content

Paper Details

Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors.
Pediatr Blood Cancer
0
2023
BRCA1/2, BRCA1/2 mutant, BRCA1/2 mutations, germline, homologous recombination (HR) pathway genes, patients, pediatric, pediatric cancer, solid and central nervous system tumors, tumor
Author NameAffiliation
Andrew K GrovesUniversity of Iowa Stead Family Children's Hospital
Aaron R ThornerDana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School
Matthew MeyersonDana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School
Matthew MeyersonBroad Institute of Harvard and MIT
Matthew MeyersonDana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School
Matthew MeyersonBroad Institute of Harvard and MIT
Andrew D CherniackDana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School
Andrew D CherniackBroad Institute of Harvard and MIT
Andrew D CherniackDana-Farber Brigham and Women's Cancer Center, Dana-Farber Cancer Institute and Harvard Medical School
Andrew D CherniackBroad Institute of Harvard and MIT
Katherine A JanewayHarvard Medical School
  • 1 - 11

Datasets

Release 1.2